The 21st-century research and development environment has changed markedly from even 15 years ago. Today's life science landscape is characterized by a much more commercial view of biotechnology than in the past, with intellectual property concerns and commercial rights attached to virtually every piece of work. The increasing awareness of potential public health risks from the transport and use of biological materials has resulted in regulatory constraints that must be negotiated to engage in productive R&D.

Our mission requires the organization to provide equitable access to its materials. For us to effectively fulfill our mission in the modern R&D environment, we must take measures to protect the rights of all parties involved in the use of its products. Such protections are put in place through the ATCC Material Transfer Agreement (MTA) (view the video below) which goes into effect  March, 2012. For questions about the MTA or licensing arrangements for using materials for a commercial use, please email us at  licensing@atcc.org.

  >Duration: ~10 minutesFile Size: 2.5MB
    Please enable audio/speakers.